Concepedia

Marin Abousaud

MA

5

Publications

120

Citations

5

H-Index

2022

Active since

Affiliations

Emory University(Current)

Astellas Pharma (United States)

Moffitt Cancer Center

Marin Abousaud is an author at Emory University specializing in cancer therapeutics, oncology, and head and neck cancer.

Top concepts

Publications per year

2022–2024

5

Publications

5

Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial

Nabil F. Saba, Conor Steuer, Asari Ekpenyong et al. · Nature Medicine · 2023 · 73 citations · Full text

, , +7

A phase II trial of pembrolizumab and cabozantinib in patients (pts) with recurrent metastatic head and neck squamous cell carcinoma (RMHNSCC).

Nabil F. Saba, Asari Ekpenyong, Ashley McCook-Veal et al. · Journal of Clinical Oncology · 2022 · 12 citations

, , +19

Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement

Raymond J. So, Julio C. Hidalgo Lopez, Samir A. Ballestas et al. · The Laryngoscope · 2023 · 12 citations · Full text

Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma

Nabil F. Saba, Stuart J. Wong, Tahseen H. Nasti et al. · JAMA Oncology · 2024 · 12 citations · Full text

Long‐Term Follow‐up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis

Samir A. Ballestas, Julio Hidalgo Lopez, Adam M. Klein et al. · The Laryngoscope · 2023 · 11 citations · Full text

Rows per page

1–5 of 5